InMode Anticipates Robust Q3 2024 Financial Results
InMode Plans to Unveil Third Quarter 2024 Financial Results
InMode Ltd. (NASDAQ: INMD), recognized as a global leader in innovative medical technologies, is gearing up to announce its financial outcomes for the third quarter of 2024. The company is expected to release its results prior to the opening of the Nasdaq market on the morning of October 30, 2024.
Anticipated Q3 Revenue Expectations
For this quarter, InMode projects revenues between $130.0 million and $130.1 million. This includes approximately $31.9 million in revenue resulting from pre-orders received during the first half of the year, which will be recognized in Q3 2024. In light of these developments, the management team has also revised its full-year guidance for 2024 to a range of $410 million to $420 million, a slight decrease from earlier estimates.
Key Financial Insights and Market Trends
The financial results for Q3 are in the process of being finalized, with preliminary insights being shared to provide investors with a glimpse into the company's performance. InMode has successfully addressed all pre-orders, improving its delivery schedule and allowing it to recognize previously deferred revenues. The management is addressing the macroeconomic challenges that have notably affected the aesthetics sector during this period.
Management Comments on Operational Adjustments
In light of the current environment, InMode remains focused on ensuring the safety of its workforce while also evaluating potential shifts in production operations to enhance efficiency and reduce risks. The company has shown adaptability and resilience in fulfilling orders and maintaining robust customer relationships.
Conference Call Details
To discuss the third-quarter financial outcomes, InMode will host a conference call on October 30 at 8:30 a.m. Eastern Time. The executive team, including Chief Executive Officer Moshe Mizrahy, Chief Financial Officer Yair Malca, and Chief Technology Officer Dr. Michael Kreindel, will be present to provide insights and answer questions.
How to Participate in the Conference Call
Participants are encouraged to pre-register for the conference call through the link provided in their communications. Upon registration, attendees will receive unique dial-in information, facilitating immediate access on the day of the call. For those opting not to pre-register, various teleconferencing numbers will be available with instructions on how to connect.
Looking Ahead: InMode's Commitment to Innovation
As a continuing innovator in the medical field, InMode has made significant advancements in developing and marketing devices that utilize cutting-edge radiofrequency technology. This has allowed the company to diversify its product offerings across several medical disciplines, including plastic surgery, dermatology, and gynecology. The company's commitment to enhancing treatment procedures illustrates its integral role in evolving medical technology.
Engaging the Investor Community
InMode aims to foster strong relationships with its investors, ensuring transparency and providing insightful discussions during the forthcoming conference call. This is an excellent opportunity for stakeholders to gain a better understanding of the company’s performance and strategies moving forward. After the call, a replay will be accessible, maintaining detailed communication with those who could not attend live.
Frequently Asked Questions
What financial results is InMode expected to report for Q3 2024?
InMode anticipates revenues between $130.0 million and $130.1 million, including revenues from pre-orders recognized in this quarter.
When is InMode's conference call scheduled?
The conference call is set for October 30, 2024, at 8:30 a.m. Eastern Time.
Who will be speaking during the conference call?
The call will feature key executives such as CEO Moshe Mizrahy, CFO Yair Malca, and CTO Dr. Michael Kreindel.
How can participants access the conference call?
Participants can pre-register for the call through a link provided, allowing them to receive dial-in instructions for easy access on the day.
What is InMode known for?
InMode is noted for its innovative medical technologies, particularly devices that leverage radiofrequency technology for a range of medical applications.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Anthology Honored by Microsoft as an Inner Circle Member for 2024-2025
- Exploring AI Innovations in the 2024 ASCAP Lab Challenge
- Iterum Therapeutics Showcases Innovative Research at IDWeek 2024
- Femasys Showcases Innovative Solutions at ASRM 2024 Expo
- Cellebrite's Upcoming Q3 2024 Financial Results Conference Call
- DTE Energy to Announce Q3 2024 Financial Results Soon
- Gentherm's Q3 2024 Results Release and Conference Call Details
- Dayforce Discover 2024: A Groundbreaking Event for HCM Leaders
- Femasys Showcasing Innovations at ASRM 2024 Congress
- Iterum Therapeutics Shares Key Findings at IDWeek 2024 Event
Recent Articles
- Elon Musk's X Exempt from New EU Digital Markets Regulations
- Pet Valu to Reveal Third Quarter 2024 Results and Insights
- Suki Secures $70 Million to Enhance AI Healthcare Solutions
- Neogen Corporation Reports First Quarter 2025 Financial Results
- Tilray Surprises with Q1 Earnings Growth Amid Revenue Shortfall
- Why Robinhood Stocks Are Driving Rapid Growth In 2024
- Virtus Investment Partners Sees Growth with $183.7 Billion AUM
- A2Z Cust2mate's Growth Strategy Unfolds in Latin America
- Aircastle Limited Reports Strong Q2 Results Highlighting Growth
- Plurilock and CrowdStrike Join Forces to Bolster Cybersecurity
- Indivior Adjusts Financial Outlook in Response to Market Trends
- Chuze Fitness Expands Offerings with CLMBR Vertical Machines
- Goldman Sachs Adjusts Microsoft Stock Target Amid AI Growth
- YXT.com Surpasses 200 Fortune 500 Clients Amid Challenges
- ServiceNow Set to Thrive with Upgraded Price Target and AI Growth
- CloudM Launches Migrate 4.0: A Revolution in Data Migration
- Zoom Video’s Future Growth: Insights and Strategies Unveiled
- Life Time Champions Expanding Pickleball Facilities Across U.S.
- Cabaletta Bio Gears Up for Growth with CABA-201 and Key Insights
- ToolsGroup Recognized as Leader in Global Supply Chain Solutions
- Analysts Boost Kyverna Therapeutics' Stock Rating Amid Promising Data
- IKEA Reports 5% Sales Decline Amid Housing Market Challenges
- Domino's Pizza Shows Resilience with Strong Earnings Performance
- Key Stock Movements: Tesla and GXO Rise, Delta and Apple Drop
- Microsoft Ranks High in CIOs' AI Investment Priorities
- Airbus Faces Challenges in Meeting 2023 Delivery Goals
- Top 3 Dynamic Stocks with Strong Upside Potential
- Market Movers: Key Insights on Pfizer, Arcadium Lithium, and Netflix
- Navigating Nasdaq 100 Gains Amid Risk Factors
- Exploring the Growth of the LED Obstruct Lighting Market
- Northisle Copper's Resource Estimate Growth Sparks Investor Excitement
- Blue Moon Metals Takes Significant Steps in Economic Assessment
- Tilray Brands Experiences Impressive Q1 2025 Growth Surge
- Melt Pharmaceuticals Concludes Phase 3 Study for MELT-300
- Revolutionizing Law Enforcement: Veritone’s AI Solutions Unleashed
- TD Bank Stock Faces Challenges with Upcoming Penalties
- Lassila & Tikanoja's Upcoming Interim Report Presentation Insights
- Accelsius to Unveil Cutting-Edge Cooling Solutions at Major Summit
- Navigating the AI Landscape: A Deep Dive into Leading Stocks
- Enovis Announces Third Quarter Results Conference Call
- Rob Walpole Elevated to CEO of Custom Goods, Enhancing Logistics Strategy
- Delta Air Lines Adjusts Revenue Forecast Amid Economic Changes
- MediWound's Innovative Study to Compare EscharEx® in Ulcer Care
- Triple Flag Achieves Remarkable Revenue Milestone in Q3 2024
- Navigating Market Fluctuations Amid Inflation Concerns
- Expro Group Highlights Upcoming Q3 2024 Earnings Call
- Foghorn Therapeutics Doses First Patient with Innovative FHD-909
- Orthofix's Upcoming Third Quarter Financial Results Announcement
- Boralex Expands Portfolio with New Wind Farm Acquisition
- Sonendo, Inc. Reports Strong Preliminary Q3 2024 Results